Can cancer treatment also kick the habit? new study tests combined approach

NCT ID NCT02540174

Completed Disease control Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether adding a structured addiction treatment program to standard cancer care helps patients with head and neck or lung cancer quit smoking and reduce alcohol use. 133 patients were randomly assigned to either the integrated program or usual care. The main goal was to see how many patients were tobacco-free at 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: integrated addiction treatment program
What this could lead to: If it works, this could show that combining addiction treatment with cancer care helps more patients quit smoking and drinking, potentially improving their overall health and cancer outcomes.
What could go wrong: This is a completed study with 133 participants, so results are available but may not apply to all patients. The program is intensive and may not be feasible in all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms lung cancer lung neoplasm Tobacco Use upper aerodigestive tract neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER UPPER AERODIGESTIVE TRACT NEOPLASMS

Contacts and locations

Locations

CHRU of Lille : Albert Calmette Hospital

Lille, 59037, France
CHRU of Lille: Huriez Hospital

Lille, 59037, France
Oscar Lambret Center

Lille, 59020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.